Dr. Srisuwananukorn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-3196Fax+1 614-293-4812
Education & Training
Indiana University School of MedicineClass of 2017
Certifications & Licensure
OH State Medical License 2023 - 2025
NY State Medical License 2020 - 2023
IL State Medical License 2017 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Applications of artificial intelligence to myeloproliferative neoplasms: a narrative review.Andrew Srisuwananukorn, Jordan E Krull, Qin Ma, Ping Zhang, Alexander T Pearson
Expert Review of Hematology. 2024-10-01 - Oral Decitabine/Cedazuridine Is an Effective Ambulatory Therapy for Patients With Myelofibrosis Refractory to JAK2 Inhibitor Therapy.Shivani Handa, Ganesh Sivakumar, Andrew Srisuwananukorn, Amylou Dueck, Douglas Tremblay
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-01 - 1 citationsHow to customize common data models for rare diseases: an OMOP-based implementation and lessons learned.Najia Ahmadi, Michele Zoch, Oya Guengoeze, Carlo Facchinello, Antonia Mondorf
Orphanet Journal of Rare Diseases. 2024-08-14
Press Mentions
New Insights Emerge on Treatment Outcomes for Accelerated or Blast-Phase Myeloproliferative NeoplasmsOctober 4th, 2024
Studies Highlight Impacts of Applying New Technologies in Everyday CareDecember 12th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
